Immunosuppressive treatment for acquired haemophilia: current practice and future directions in Germany, Austria and Switzerland
暂无分享,去创建一个
L. Alberio | J. Oldenburg | P. Knöbl | M. Spannagl | R. Klamroth | A. Tiede | M. Krause | B. Brand | R. Grossmann | U. Geisen | A. Huth‐Kühne
[1] G. Lippi,et al. Acquired factor VIII inhibitors. , 2008, Blood.
[2] T. Baglin,et al. Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation. , 2007, Blood.
[3] H. Vetter,et al. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in vivo immunomodulating concept. , 2005, Blood.
[4] Mark I L Watling. The European Acquired Haemophilia Registry , 2004, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[5] J. Delgado,et al. Acquired Haemophilia: Review and Meta‐Analysis Focused on Therapy and Prognostic Factors , 2003, British journal of haematology.
[6] C. Kessler,et al. Treatment of acquired hemophilia. , 1994, Seminars in hematology.
[7] G. Lippi,et al. How I treat Acquired factor VIII inhibitors , 2008 .
[8] W. Sperr,et al. Rituximab for the treatment of acquired antibodies to factor VIII. , 2007, Haematologica.